Oncology Practice Insider

On June 22, 2020, ASCO posted the Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended.

On April 23, ASCO posted the Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck guideline.

ASCO Clinical Practice Guidelines Committee (CPGC) is soliciting topics for clinical practice guideline development, and the CPGC would like to invite members of other ASCO Committees to participate in the process. The CPGC has delegated the identification and prioritization of guideline topics to Guideline Advisory Groups (AGs). The AGs will consider topics suggested by the ASCO membership when revisiting current priorities and will submit the prioritized list to the CPGC in the fall.

On March 31, ASCO posted the Systemic Therapy for Melanoma Guideline. Immunotherapy is recommended as the standard for BRAF wild-type, unresectable/metastatic melanoma, while either immunotherapy or BRAF/MEK targeted therapy is recommended for BRAF mutant disease.

On March 9, 2020, ASCO published the Treatment of Patients with Late-Stage Colorectal Cancer Resource-Stratified Guideline. The expert panel provided recommendations for diagnosis, systemic treatment, and surgery.

ASCO published the following new guidelines:

ASCO published the following new guidelines: